β受体阻滞剂治疗的现状。
Current status of Beta blocker therapy.
出版信息
Can Fam Physician. 1980 May;26:706-9.
Abstract
Beta-adrenergic blocking agents are an increasingly important class of drugs to the family physician. Diseases such as ischemic heart disease, hypertension and hyperthyroidism have responded dramatically to beta-blocking therapy. This article summarizes some of the current knowledge on the beta-receptor, the indications for beta-receptor blocking therapy, and the properties of the five beta-blocking agents currently available to Canadian physicians.
摘要
β-肾上腺素能阻断剂是家庭医生越来越重要的一类药物。像缺血性心脏病、高血压和甲状腺机能亢进等疾病对β-阻断治疗反应非常明显。本文概述了一些关于β受体的最新知识、β受体阻断治疗的适应证以及加拿大医生目前可使用的五种β阻断剂的特性。
相似文献
1
Current status of Beta blocker therapy.
Can Fam Physician. 1980 May;26:706-9.
2
Alpha- and beta-receptor blocking drugs in the treatment of hypertension.
Curr Probl Cardiol. 1979 Jan;3(10):1-53.
3
Physician characteristics and the initiation of beta-adrenergic blocking agent therapy after acute myocardial infarction in a managed care population.
Am J Manag Care. 2001 Jul;7(7):717-23.
4
[Beta-adrenergic receptor blocker poisoning].
Medicina (Kaunas). 2007;43(7):587-93.
5
COMBINED PHARMACOLOGICAL THERAPY INCLUDING SEVERAL ANTIARRHYTHMIC AGENTS FOR TREATMENT OF DIFFERENT DISORDERS OF CARDIAC RHYTHM.
Georgian Med News. 2021 Jun(315):85-93.
6
Mechanisms of action and the clinical pharmacology of beta-adrenergic blocking drugs.
Am J Med. 1984 Oct 5;77(4A):119-27. doi: 10.1016/s0002-9343(84)80047-9.
7
The heart and hyperthyroidism. Use of beta-adrenergic blocking drugs.
Med Clin North Am. 1975 Sep;59(5):1193-9. doi: 10.1016/s0025-7125(16)31967-8.
8
Beta-blocking drugs and coronary heart disease.
Cardiovasc Drugs Ther. 1997 May;11 Suppl 1:219-25. doi: 10.1023/a:1007711025487.
9
[Therapy with beta-blocking-agents (author's transl)].
MMW Munch Med Wochenschr. 1978 Nov 3;120(44):1461-6.
10
[Spectrum of effects of beta receptor blockade in cardiac arrhythmias].
Z Kardiol. 1986;75 Suppl 5:41-6.
本文引用的文献
1
Differentiation of receptor systems activated by sympathomimetic amines.
Nature. 1967 May 6;214(5088):597-8. doi: 10.1038/214597a0.
2
The use of propranolol in the surgical treatment of thyrotoxic patients.
Ann Surg. 1973 Jun;177(6):643-7.
3
Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties.
N Engl J Med. 1974 May 2;290(18):984-8. doi: 10.1056/NEJM197405022901802.
4
Controlled clinical trial of beta-adrenergic blockade in hypertrophic obstructive cardiomyopathy (HOCM).
Br Heart J. 1972 Sep;34(9):963.
5
Beta-adrenergic receptor blocking drugs in hypertension.
Drugs. 1974;7(1):85-105. doi: 10.2165/00003495-197407010-00006.
6
Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.
Drugs. 1974;7(1):1-7. doi: 10.2165/00003495-197407010-00001.
7
Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.
Drugs. 1974;7(1):118-29. doi: 10.2165/00003495-197407010-00008.
8
Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
Drugs. 1974;7(1):39-47. doi: 10.2165/00003495-197407010-00003.
9
Thyroid storm and its management.
N Engl J Med. 1974 Dec 26;291(26):1396-8. doi: 10.1056/NEJM197412262912607.
10
Suppression by oxprenolol of adrenergic response to stress.
Lancet. 1972 Aug 5;2(7771):256-8. doi: 10.1016/s0140-6736(72)91689-3.
Zotero 插件